Claudia Voena

4.6k total citations · 1 hit paper
57 papers, 3.2k citations indexed

About

Claudia Voena is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Claudia Voena has authored 57 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 21 papers in Molecular Biology and 17 papers in Hematology. Recurrent topics in Claudia Voena's work include Lymphoma Diagnosis and Treatment (15 papers), Multiple Myeloma Research and Treatments (14 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Claudia Voena is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Multiple Myeloma Research and Treatments (14 papers) and Chronic Lymphocytic Leukemia Research (10 papers). Claudia Voena collaborates with scholars based in Italy, United States and Denmark. Claudia Voena's co-authors include Roberto Chiarle, Chiara Ambrogio, Giorgio Inghirami, Paolo Corradini, Roberto Piva, Alessandro Pileri, Mario Boccadoro, Marco Ladetto, Monica Astolfi and Corrado Tarella and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Claudia Voena

57 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The anaplastic lymphoma kinase in the pathogenesis of cancer

2007 643 citations Roberto Chiarle, Claudia Voena et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claudia Voena Italy	29	1.4k	1.2k	992	768	735	57	3.2k
Scott Ely United States	28	1.3k 0.9×	1.6k 1.3×	872 0.9×	1.1k 1.4×	674 0.9×	89	3.4k
Alejandro Martı́n Spain	25	845 0.6×	1.4k 1.1×	909 0.9×	861 1.1×	465 0.6×	128	2.8k
Martina Rudelius Germany	31	1.1k 0.8×	902 0.7×	440 0.4×	463 0.6×	590 0.8×	89	3.0k
Markus Warmuth United States	27	1.7k 1.2×	930 0.8×	1.2k 1.2×	412 0.5×	288 0.4×	48	3.1k
Mathijs Baens Belgium	29	1.5k 1.1×	959 0.8×	742 0.7×	842 1.1×	1.2k 1.6×	51	3.7k
Sami N. Malek United States	31	1.6k 1.2×	901 0.7×	583 0.6×	945 1.2×	946 1.3×	77	3.3k
Leila Alland United States	19	2.1k 1.5×	2.1k 1.7×	1.3k 1.3×	267 0.3×	323 0.4×	40	5.0k
Hetty E. Carraway United States	35	1.7k 1.2×	1.1k 0.9×	1.4k 1.4×	265 0.3×	488 0.7×	212	3.6k
June H. Myklebust Norway	31	1.3k 1.0×	1.8k 1.5×	396 0.4×	847 1.1×	1.9k 2.6×	78	4.0k
John Powell United States	16	1.4k 1.0×	887 0.7×	370 0.4×	876 1.1×	915 1.2×	22	2.9k

Countries citing papers authored by Claudia Voena

Since Specialization

Citations

This map shows the geographic impact of Claudia Voena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Voena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Voena more than expected).

Fields of papers citing papers by Claudia Voena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Voena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Voena. The network helps show where Claudia Voena may publish in the future.

Co-authorship network of co-authors of Claudia Voena

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Voena. A scholar is included among the top collaborators of Claudia Voena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Voena. Claudia Voena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Voena, Claudia, Chiara Ambrogio, Fabio Iannelli, & Roberto Chiarle. (2025). ALK in cancer: from function to therapeutic targeting. Nature reviews. Cancer. 25(5). 359–378. 6 indexed citations

Menotti, Matteo, Cinzia Martinengo, Chiara Ambrogio, et al.. (2023). Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma. Frontiers in Oncology. 12. 2 indexed citations

Aroldi, Andrea, Mario Mauri, Daniele Ramazzotti, et al.. (2023). Effects of blocking CD24 and CD47 ‘don't eat me’ signals in combination with rituximab in mantle‐cell lymphoma and chronic lymphocytic leukaemia. Journal of Cellular and Molecular Medicine. 27(20). 3053–3064. 11 indexed citations

Mecca, Carmen, Qi Wang, Chiara Ambrogio, et al.. (2021). Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. Blood. 139(5). 717–731. 27 indexed citations

Compagno, Mara, Qi Wang, Taek-Chin Cheong, et al.. (2017). Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells. Nature. 542(7642). 489–493. 92 indexed citations

Choudhari, Ramesh, Valerio Giacomo Minero, Matteo Menotti, et al.. (2016). Redundant and nonredundant roles for Cdc42 and Rac1 in lymphomas developed in NPM-ALK transgenic mice. Blood. 127(10). 1297–1306. 20 indexed citations

Voena, Claudia & Roberto Chiarle. (2016). Advances in cancer immunology and cancer immunotherapy.. PubMed. 21(114). 125–33. 75 indexed citations

Ceccon, Monica, Luca Mologni, Teresa Poggio, et al.. (2015). Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency. Oncogene. 35(29). 3854–3865. 29 indexed citations

Alberti, Diego, Nicoletta Protti, Antonio Toppino, et al.. (2015). A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment. Nanomedicine Nanotechnology Biology and Medicine. 11(3). 741–750. 52 indexed citations

10.

Ambrogio, Chiara, Francisco javier García Carmona, August Vidal, et al.. (2014). Modeling Lung Cancer Evolution and Preclinical Response by Orthotopic Mouse Allografts. Cancer Research. 74(21). 5978–5988. 18 indexed citations

11.

Martinengo, Cinzia, Teresa Poggio, Matteo Menotti, et al.. (2014). ALK-Dependent Control of Hypoxia-Inducible Factors Mediates Tumor Growth and Metastasis. Cancer Research. 74(21). 6094–6106. 44 indexed citations

12.

Voena, Claudia, Filomena Di Giacomo, Elena Panizza, et al.. (2013). The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1. Oncogenesis. 2(4). e43–e43. 26 indexed citations

13.

Ambrogio, Chiara, Cinzia Martinengo, Claudia Voena, et al.. (2009). NPM-ALK Oncogenic Tyrosine Kinase Controls T-Cell Identity by Transcriptional Regulation and Epigenetic Silencing in Lymphoma Cells. Cancer Research. 69(22). 8611–8619. 71 indexed citations

14.

Ambrogio, Chiara, Claudia Voena, Andrea D. Manazza, et al.. (2008). The Anaplastic Lymphoma Kinase Controls Cell Shape and Growth of Anaplastic Large Cell Lymphoma through Cdc42 Activation. Cancer Research. 68(21). 8899–8907. 41 indexed citations

15.

Voena, Claudia, Chiara Conte, Chiara Ambrogio, et al.. (2007). The Tyrosine Phosphatase Shp2 Interacts with NPM-ALK and Regulates Anaplastic Lymphoma Cell Growth and Migration. Cancer Research. 67(9). 4278–4286. 70 indexed citations

16.

Chiarle, Roberto, Claudia Voena, Chiara Ambrogio, Roberto Piva, & Giorgio Inghirami. (2007). The anaplastic lymphoma kinase in the pathogenesis of cancer. Nature reviews. Cancer. 8(1). 11–23. 643 indexed citations breakdown →

17.

Voena, Claudia, Claudia Castellino, Paola Omedè, et al.. (2002). Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34⁺ cells with small‐ and large‐scale Miltenyi cell sorting system. British Journal of Haematology. 117(3). 642–645. 11 indexed citations

18.

Corradini, Paolo, Claudia Voena, Monica Astolfi, et al.. (2001). Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer. Annals of Oncology. 12(12). 1693–1698. 58 indexed citations

19.

Voena, Claudia, Marco Ladetto, Monica Astolfi, et al.. (1997). A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. Leukemia. 11(10). 1793–1798. 76 indexed citations

20.

Corradini, Paolo, Dario Ferrero, Claudia Voena, et al.. (1993). THE MUTATION OF N‐RAS ONCOGENE DOES NOT INVOLVE MYELOID AND ERYTHROID LINEAGES IN A CASE OF MULTIPLE MYELOMA. British Journal of Haematology. 83(4). 672–673. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact